SearchCME LoginCE Login Show Cart
NACE: National Association For Continuing Education 866-266-6223 9a am to 5 pm EST Mon-Fri
CME Course Description
   
Login to view
Course Activities.

CME Live Virtual Conferences

Go Back


National Association for Continuing Education
Speaker
James Wymer, MD, PHD, CPI, FAAN
University of Florida
Professor of Neurology,
Director of Neuromuscular Division
Gainesville, FL

Moderator
Gregg Sherman, MD
Chief Medical Officer/Course Director
National Association for Continuing Education
Plantation, FL

Title
: Crying and Laughing Inappropriately? Think Pseudobulbar Affect
Activity/Course #:
: NCME384
Cost:
: Free
Release/Start Date:
: Jul 30 2019
Expiration Date:
: Jul 29 2020
Topics:
: Primary Care Medicine
Target Audience:
: Primary Care Providers, Psychiatrists, Neurologists
Format:
: Webcast
Estimated Time To Complete CME Activity:
: 1.0 Hour
Credit(s):
: 1.0 AMA PRA Category I Credit(s)
1.0 AANP Contact hour(s) which includes 0.50 pharmacology hour(s)
Hardware/Software Requirements:
Program Summary
Pseudobulbar affect (PBA) is a neurologic syndrome of emotional affect disinhibition, characterized by frequent, uncontrollable emotional outbursts of crying and/or laughing that are usually exaggerated and inappropriate to the stimulus, and may be mood incongruent. Some patients may also display outbursts of anger or frustration. PBA occurs in association with a variety of neurological diseases, and may cause severe distress, embarrassment, and social dysfunction. This activity will review the epidemiology and impact of PBA and examine the diagnostic criteria and evidence-based therapies to effectively manage your patients with PBA.

This webcast was recorded live at the Emerging Challenges in Primary Care 2019 Live Virtual Symposium and is being used with the permission of the presenters.

Learning Objectives
 
After completing this program participants should be able to:
  1. Review the epidemiology and impact of pseudobulbar affect (PBA)
  2. Discuss the importance of early recognition of PBA in the primary care, nursing home, and rehabilitation settings
  3. Describe diagnostic tools and criteria for objective diagnosis of PBA
  4. Utilize evidence-based therapies to effectively manage PBA
 
How to obtain the CME Certificate
  1. Register for the course at www.naceonline.com.
  2. View the content.
  3. Complete and submit the post-test and evaluation.
  4. A minimum passing score of 60% must be earned on the post-test in order to complete the CME activity.
  5. Print your CME certificate
Sponsored and Certified By
National Association for Continuing Education
Accreditation Designation Statement
The National Association for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The National Association for Continuing Education designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The National Association for Continuing Education is approved as a provider of nurse practitioner continuing education by the American Association of Nurse Practitioners. AANP Provider Number 121222. This program has been approved for 1 contact hour of continuing education which includes 0.50 pharmacology hours.
Faculty Disclosure Policy
Policy on Faculty and Provider Disclosure: It is the policy of the accredited providers to ensure fair balance, independence, objectivity and scientific rigor in all activities. All faculty participating in CME activities sponsored by the accredited providers are required to present evidence-based data, identify and reference off-label product use and disclose all relevant financial relationships. All planners are also required to disclose all relevant financial relationships. Disclosure information is provided below.

Speaker
Dr. Wymer has no relationships to disclose

Contributing Faculty
Alejandro Alva, MD serves as a speaker for Sunovion.

Jason P. Caplan, MD, FAPA, FACLP serves as a speaker for Neurocrine Biosciences and Acadia Pharmaceuticals. Dr. Caplan also serves as an advisory board member for Alkermes and as a speaker and consultant for Avanir Pharmaceuticals.

Activity Planning Committe
Gregg Sherman, MD, has no relationships to disclose.

Josh Kilbridge, Medical Writer, has no relationships to disclose.

Michelle Frisch, MPH, has no relationships to disclose.

Daniela Hiedra, BA, has no relationships to disclose.

Sandy Bihlmeyer, MEd, has no relationships to disclose.
Commercial Support
This educational activity is supported by an educational grant from Avanir Pharmaceuticals.